In contrast, TyG index, as a new surrogate indicator of IR, is widely used to predict the risk and severity of metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases.[20–22] The TyG index calculation does not necessitate insulin quantification, rendering it suitable for all individuals. The gene discussed is INS; the disease is metabolic syndrome.